Search

WASHINGTON: 60 Degrees Pharmaceuticals Inc has issued the following news release: 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the 'Company'), a pharmaceutical company focused on developing new medicines for infectious [...]

WASHINGTON: 60 Degrees Pharmaceuticals, Inc., announces that it has been awarded a fixed-price contract with the United States Army Medical Materiel Development Activity to support commercial validation of new bottle [...]

WASHINGTON:60 Degrees Pharmaceuticals has signed clinical trial agreements with Tufts Medical Center, Yale University, and Rhode Island Hospital for the Tafenoquine for Babesiosis study. The trial will evaluate the efficacy [...]

WASHINGTON: 60 Degrees Pharmaceuticals, Inc., (NASDAQ: SXTP, SXTPW) ('60 Degrees Pharmaceuticals' or the 'Company'), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced that the U.S. [...]

WASHINGTON: 60 Degrees Pharmaceuticals, Inc. announces it will, through its majority-owned subsidiary 60P Australia Pty Ltd, sponsor a series of animal studies to investigate whether single-dose parenteral administration of tafenoquine [...]

Washington: 60 DEGREES PHARMACEUTICALS, INC., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Feb 20, 2024: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. [...]

WASHINGTON: 60 Degrees Pharmaceuticals, Inc. announces that it has appointed Kristen Landon to the newly created role of Chief Commercial Officer, effective immediately. Ms. Landon is an accomplished commercial leader [...]

Marin Software Incorporated MRIN shares dipped 50% to $0.19 in pre-market trading. Sidus Space, Inc. SIDU shares fell 37.9% to $5.40 in pre-market trading. Sidus Space priced its public offering [...]

NovaBay Pharmaceuticals, Inc. NBY gained 71.3% to $0.2810 in pre-market trading after gaining around 8% on Friday. NovaBay Pharmaceuticals and Sonoma Pharmaceuticals recently agreed to market Avenova-branded products in the [...]

WASHINGTON: 60 Degrees Pharmaceuticals, Inc. (60P), a pharmaceutical company focused on developing new medicines for infectious diseases, announced that, following a Type C meeting held on January 17, 2024 with [...]

WASHINGTON: Sixty Degrees Pharmaceuticals has issued the following news release: 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ('60P' or the 'Company'), a pharmaceutical company focused on developing new medicines for [...]

WASHINGTON: 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (60P or the Company), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today the approval of an Investigational [...]

WASHINGTON: Sixty Degrees Pharmaceuticals has issued the following news release: 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ('60P' or the 'Company'), a pharmaceutical company focused on developing new medicines for [...]

Safe and Green Development Corporation SGD shares rose 150.5% to $7.59 in pre-market trading. Safe And Green Development shares jumped around 559% on Thursday after the company said it does [...]

WASHINGTON: 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ('60P' or the 'Company'), a pharmaceutical company focused on developing new medicines for infectious diseases, announced that its subsidiary, 60P Australia Pty [...]

WASHINGTON: 60 Degrees Pharmaceuticals ('60P') (Nasdaq: SXTP), specialists in developing and marketing medicines for infectious diseases, today announced that the United States Patent and Trademark Office (USPTO) has awarded 60P [...]

WASHINGTON: Sixty Degrees Pharmaceuticals has issued the following news release: 60 Degrees Pharmaceuticals ('60P'), specialists in developing and marketing medicines for infectious diseases, today announced that the United States Patent [...]